TNGX Upgraded
Jefferies upgrades Tango Therapeutics to Buy and raises price target to $60
Jefferies analyst Maury Raycroft upgrades Tango Therapeutics (NASDAQ: TNGX ) from Hold to Buy and raises the price target from $27 to $60.
Jefferies upgrades Tango Therapeutics to Buy and raises price target to $60
Jefferies analyst Maury Raycroft upgrades Tango Therapeutics (NASDAQ: TNGX ) from Hold to Buy and raises the price target from $27 to $60.